FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891396683> ?p ?o ?g. }

• W2891396683 endingPage "764" @default.
• W2891396683 startingPage "756" @default.
• W2891396683 abstract "Prurigo nodularis is a chronic dermatologic condition involving the development of multiple cutaneous nodules in the setting of intractable pruritus. Given emerging treatment options for this difficult-to-treat condition, a current review of therapeutics is needed. A systematic review was performed for clinical studies investigating prurigo nodularis treatment published from 1990 to present including ≥5 subjects. A total of 35 articles were assigned a level of evidence according to the Oxford Center for Evidence-based Medicine. All 5 studies investigating topical agents, including corticosteroids, calcineurin inhibitors, calcipotriol, and capsaicin, conveyed some beneficial effect with level of evidence 2b or higher. Six of 8 reports investigating photo- and photochemotherapy achieved levels of evidence 2b or greater and showed good partial response rates. Thalidomide was studied by 6 reports providing evidence of good symptom response, only 2 of which were rated level 2b or greater. Cyclosporine and methotrexate have demonstrated benefit in 4 combined studies, albeit with level 4 evidence. Pregabalin, amitriptyline, paroxetine, fluvoxamine, and neurokinin-1 receptor antagonists have demonstrated promising evidence in 5 level 2b studies. Higher-powered studies and additional randomized controlled trials are needed for the evaluation of safe and efficacious systemic treatment options for prurigo nodularis. Prurigo nodularis is a chronic dermatologic condition involving the development of multiple cutaneous nodules in the setting of intractable pruritus. Given emerging treatment options for this difficult-to-treat condition, a current review of therapeutics is needed. A systematic review was performed for clinical studies investigating prurigo nodularis treatment published from 1990 to present including ≥5 subjects. A total of 35 articles were assigned a level of evidence according to the Oxford Center for Evidence-based Medicine. All 5 studies investigating topical agents, including corticosteroids, calcineurin inhibitors, calcipotriol, and capsaicin, conveyed some beneficial effect with level of evidence 2b or higher. Six of 8 reports investigating photo- and photochemotherapy achieved levels of evidence 2b or greater and showed good partial response rates. Thalidomide was studied by 6 reports providing evidence of good symptom response, only 2 of which were rated level 2b or greater. Cyclosporine and methotrexate have demonstrated benefit in 4 combined studies, albeit with level 4 evidence. Pregabalin, amitriptyline, paroxetine, fluvoxamine, and neurokinin-1 receptor antagonists have demonstrated promising evidence in 5 level 2b studies. Higher-powered studies and additional randomized controlled trials are needed for the evaluation of safe and efficacious systemic treatment options for prurigo nodularis." @default.
• W2891396683 created "2018-09-27" @default.
• W2891396683 creator A5008757192 @default.
• W2891396683 creator A5032105584 @default.
• W2891396683 creator A5032300502 @default.
• W2891396683 creator A5080830504 @default.
• W2891396683 date "2019-03-01" @default.
• W2891396683 modified "2023-09-30" @default.
• W2891396683 title "A systematic review of evidence-based treatments for prurigo nodularis" @default.
• W2891396683 cites W1537248210 @default.
• W2891396683 cites W1564991779 @default.
• W2891396683 cites W1589746310 @default.
• W2891396683 cites W1756303613 @default.
• W2891396683 cites W1943485699 @default.
• W2891396683 cites W1945919302 @default.
• W2891396683 cites W1948769908 @default.
• W2891396683 cites W1972273364 @default.
• W2891396683 cites W1972486576 @default.
• W2891396683 cites W1985940569 @default.
• W2891396683 cites W2000265500 @default.
• W2891396683 cites W2001395012 @default.
• W2891396683 cites W2002219974 @default.
• W2891396683 cites W2004932306 @default.
• W2891396683 cites W2013931408 @default.
• W2891396683 cites W2016342605 @default.
• W2891396683 cites W2018452170 @default.
• W2891396683 cites W2022623011 @default.
• W2891396683 cites W2024848742 @default.
• W2891396683 cites W2032389176 @default.
• W2891396683 cites W2037247664 @default.
• W2891396683 cites W2040663311 @default.
• W2891396683 cites W2043484392 @default.
• W2891396683 cites W2045585767 @default.
• W2891396683 cites W2045612622 @default.
• W2891396683 cites W2052172983 @default.
• W2891396683 cites W2052781883 @default.
• W2891396683 cites W2064565907 @default.
• W2891396683 cites W2068736424 @default.
• W2891396683 cites W2072689033 @default.
• W2891396683 cites W2072860089 @default.
• W2891396683 cites W2073407277 @default.
• W2891396683 cites W2077529892 @default.
• W2891396683 cites W2080477042 @default.
• W2891396683 cites W2085105489 @default.
• W2891396683 cites W2089818296 @default.
• W2891396683 cites W2101425240 @default.
• W2891396683 cites W2102673448 @default.
• W2891396683 cites W2108606621 @default.
• W2891396683 cites W2118209059 @default.
• W2891396683 cites W2119255196 @default.
• W2891396683 cites W2124200253 @default.
• W2891396683 cites W2146758289 @default.
• W2891396683 cites W2156525755 @default.
• W2891396683 cites W2158978675 @default.
• W2891396683 cites W2161474942 @default.
• W2891396683 cites W2168504907 @default.
• W2891396683 cites W2211747292 @default.
• W2891396683 cites W2321739214 @default.
• W2891396683 cites W2330423699 @default.
• W2891396683 cites W2400571301 @default.
• W2891396683 cites W2560241836 @default.
• W2891396683 cites W2593200577 @default.
• W2891396683 cites W2596871886 @default.
• W2891396683 cites W2603329326 @default.
• W2891396683 cites W2752172051 @default.
• W2891396683 cites W2761542407 @default.
• W2891396683 cites W2765925403 @default.
• W2891396683 cites W2785950685 @default.
• W2891396683 cites W2790225701 @default.
• W2891396683 doi "https://doi.org/10.1016/j.jaad.2018.09.020" @default.
• W2891396683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30261199" @default.
• W2891396683 hasPublicationYear "2019" @default.
• W2891396683 type Work @default.
• W2891396683 sameAs 2891396683 @default.
• W2891396683 citedByCount "51" @default.
• W2891396683 countsByYear W28913966832019 @default.
• W2891396683 countsByYear W28913966832020 @default.
• W2891396683 countsByYear W28913966832021 @default.
• W2891396683 countsByYear W28913966832022 @default.
• W2891396683 countsByYear W28913966832023 @default.
• W2891396683 crossrefType "journal-article" @default.
• W2891396683 hasAuthorship W2891396683A5008757192 @default.
• W2891396683 hasAuthorship W2891396683A5032105584 @default.
• W2891396683 hasAuthorship W2891396683A5032300502 @default.
• W2891396683 hasAuthorship W2891396683A5080830504 @default.
• W2891396683 hasConcept C126322002 @default.
• W2891396683 hasConcept C128057223 @default.
• W2891396683 hasConcept C141071460 @default.
• W2891396683 hasConcept C142724271 @default.
• W2891396683 hasConcept C16005928 @default.
• W2891396683 hasConcept C168563851 @default.
• W2891396683 hasConcept C19648533 @default.
• W2891396683 hasConcept C204787440 @default.
• W2891396683 hasConcept C2776009542 @default.
• W2891396683 hasConcept C2776266956 @default.
• W2891396683 hasConcept C2776364478 @default.
• W2891396683 hasConcept C2778329239 @default.
• W2891396683 hasConcept C2779609412 @default.

• next